CIK 0001858685 · <br>Emerging growth company
Biofrontera Inc.
Sign in to watch- Tickers
- BFRI BFRIW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473765675
- Phone
- 781-245-1325
- Business address
- 120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, 01801
Securities
- BFRI Common Stock Nasdaq
- BFRIW Common stock Nasdaq
- 8-K Event Regulation FD disclosure · Other events
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-A12B Other Registration of Securities
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise Chief Executive Officer acquired 56,689 shares (option exercise)
- 4 Option exercise Executive Chairman acquired 113,379 shares (option exercise)
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- SC 13D Stake Beneficial Ownership Report
Page 12 of 19 · 365 filings